MedMen Enterprises Inc.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MedMen Enterprises, Inc. engages in the manufacture and marketing of cannabis products. It operates through the following geographical segments: California, Illinois, Nevada, Arizona, and Massachusetts. The company was founded by Adam Bierman and Andrew Modlin on May 21, 1987 and is headquartered in Boca Raton, FL.

Almost three-quarters of all marijuana purchased in California this year will be of the illicit variety.

California's Cannabis Black Market Is Insanely Larger Than Its Legal Market

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Cowen analyst Vivien Azer initiated coverage Friday of five multi-state cannabis operators, saying she's bullish on those that rely on the consumer packaged goods model given the higher margins, especially relative to those relying on the retail model.

Cowen is bullish marijuana companies with CPG model, bearish on MedMen given retail reliance

MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF) announced Tuesday that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired concerning the planned acquisition of PharmaCann LLC.

MedMen Says Conditions Satisfied To Close On PharmaCann Acquisition

Two of these three states should be billion-dollar cannabis markets by 2024.

These 3 States Will Begin Selling Recreational Pot Fairly Soon

Trulieve Cannabis Corp.

Is it time for investors to head for the exit?

Earnings Forecasts for U.S. Pot Stocks Are Starting to Crumble

Here's a hint: The outlook for legalization looks quite sunny.

You Might Be Surprised by Which State Could be Headed Towards Legalizing Recreational Pot

The dispensary operator also announced a new cannabis rewards program.

Marijuana Stock MedMen Enterprises to Offer Delivery in California

Canopy Growth

For some readers, the word Zeitgeist would be a foreign one, the 'spirit of the time' references the defining mood of a particular time period. In this regard, a thing's Zeitgeist could exist on a spectrum when looked at over multiple time periods.

MedMen Vs. Canopy Growth: Towards A New Zeitgeist

U.S. cannabis retailer MedMen Enterprises Inc (CSE: MMEN) (OTC: MMNFF) announced Monday the start of its delivery service across California, allowing consumers to experience the comfort of home delivery.

MedMen Starts To Offer Cannabis Delivery Services Across California

With up to 196% upside, should these cannabis stocks be in your portfolio?

10 Marijuana Stocks Wall Street Thinks Will Double

Innovative Industrial Properties

Which stock wins in a matchup between a top cannabis retailer and the leading marijuana REIT?

Better Marijuana Stock: MedMen vs. Innovative Industrial Properties

Tilray Brands

MedMen stock jumped over the counter on cost-cutting plans. Most Canadian marijuana stocks rose ahead of Tilray earnings due after the close.

Marijuana Stocks: MedMen Jumps On Cost Cuts, Sales; Tilray Earnings Due Late

This figure is a complete head-scratcher in an otherwise fast-growing industry.

The Craziest Marijuana Statistic You'll Ever See

MedMen Enterprises Inc. MMNFF, -1.10% MMEN, +0.00% reported Tuesday preliminary fourth-quarter revenue excluding acquisitions of $42.0 million, up 14.8% from the third quarter's $36.6 million.

MedMen Q4 revenue rises 15% from previous quarter, gross margins slip

Big names don't necessarily make for the best investments.

2 U.S. Marijuana Stocks to Buy and 1 to Avoid

CannTrust Holdings

HEXO Corp

Aurora Cannabis

Aphria

Cronos Group

OrganiGram Holdings Inc.

The outlook for cannabis stocks isn't nearly as green as it used to be.

Earnings Estimates Are Plunging for These 12 Pot Stocks

Catalyst Pharmaceuticals

The small-cap healthcare stocks Catalyst Pharmaceuticals and MedMen Enterprises have enormous upside potential.

2 Small-Cap Stocks That Could Make You Rich

Aleafia Health and MedMen Enterprises are two penny pot stocks worth keeping tabs on.

2 Penny Stock Marijuana Plays That Could Make You Rich

This high-growth and budding industry comes with one must-know warning.

The Most Important Thing to Know About Investing in Marijuana Stocks

Luxury cannabis lifestyle brand The Tree Trunk Corporation announced Tuesday the start of its new accessories collection created in partnership with a renowned cannabis retailer MedMen Enterprises Inc.

Tree Trunk Brand, MedMen Introduce New Accessories Collection In California

Cannabis retailer MedMen Enterprises (OTCQX: MMNFF)(CSE:MMEN) announced Wednesday it gained an additional equity commitment from Gotham Green Partners in the amount of $30 million.

MedMen Enterprises Gets $30M Support From Gotham Green Partners

U.S.-based cannabis company MedMen Enterprises Inc. MMNFF, +3.09% said Wednesday it received an additional $30 million equity investment from Gotham Green Partners, with participation from Wicklow Capital.

MedMen receives additional $30 million equity investment led by Gotham Green Partners

A number of popular pot stocks regained their luster last month.

The 6 Best Marijuana Stocks in June

MedMen is experiencing strong revenue growth and will see its operational costs contract.

MedMen Enterprises: Strong Growth And Fledgling Moat Will Push Shares Higher

These cannabis stocks should see sales growth of at least 161% next year.

News for MedMen Enterprises Inc. Stock (MMNFF)